Powering Precision Proteomics
Alamar Biosciences, Inc. is a life science tools company founded in 2018 and headquartered in Fremont, California. The company develops and commercializes the NULISA platform — a next-generation proteomics technology enabling ultra-high sensitivity protein quantification at scale. Alamar's solutions are used in biomarker discovery, early disease detection (including cancer and neurodegenerative diseases), and pharmaceutical research. The company has raised over $170M and serves academic research centers and biopharma customers globally.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account